Teladoc Health insider files to sell 17,138 common shares

Teladoc Health insider plans to sell recently vested shares.

Rhea-AI Filing Summary

Teladoc Health insider plans to sell recently vested shares. A holder has filed notice to sell 17,138 shares of Teladoc Health common stock through Fidelity Brokerage Services on or about 12/11/2025, with an aggregate market value of $130,836.63. The filing notes that 177,473,405 Teladoc shares were outstanding, giving context for the size of this planned sale.

The 17,138 shares to be sold were acquired on 12/10/2025 via restricted stock vesting as compensation from the issuer. The same seller, Charles Divita, previously sold 16,787 Teladoc common shares on 09/11/2025 for gross proceeds of $127,435.15. By signing the notice, the seller represents that he is not aware of undisclosed material adverse information about Teladoc’s operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for TDOC disclose?

The filing discloses that a Teladoc Health shareholder plans to sell 17,138 common shares through Fidelity Brokerage Services, with an aggregate market value of $130,836.63.

How many Teladoc (TDOC) shares are planned to be sold under this Form 144?

The notice covers the planned sale of 17,138 Teladoc Health common shares, which were recently acquired through restricted stock vesting as compensation.

When were the TDOC shares being sold acquired and how?

The 17,138 Teladoc shares were acquired on 12/10/2025 via restricted stock vesting from the issuer as compensation.

What is the approximate value of the Teladoc shares to be sold in this filing?

The planned sale has an aggregate market value of $130,836.63 based on the figures disclosed for the 17,138 TDOC shares.

How many Teladoc (TDOC) shares were outstanding according to the Form 144?

The filing states that 177,473,405 Teladoc Health common shares were outstanding, providing context for the scale of the planned sale.

Has this seller recently sold other Teladoc shares?

Yes. The filing reports that Charles Divita sold 16,787 Teladoc common shares on 09/11/2025 for gross proceeds of $127,435.15 during the past three months.

What representation does the seller make in the Teladoc Form 144 notice?

By signing the notice, the seller represents that he does not know any material adverse information about Teladoc’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/11/2025 - 03:46 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001347535
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Teladoc Health, Inc.
SEC File Number	001-37477
Address of Issuer	155 E 44TH STREET SUITE 1700 NEW YORK NEW YORK 10017
Phone	2036352002
Name of Person for Whose Account the Securities are To Be Sold	DIVITA CHARLES III
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	17138	130836.63	177473405	12/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/10/2025	Restricted Stock Vesting	Issuer			17138	12/10/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Charles Divita 155 E 44th Street, Suite 1700 New York NY 10017	Common	09/11/2025	16787	127435.15

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	12/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jared Cook, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Charles Divita
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)